CIK 0001835022 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Coya Therapeutics, Inc.
Sign in to watch- Ticker
- COYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650.739.3939
- Business address
- 12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX, 77024
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-09 | Pavao Mark H Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-01-22 | SNYDER DAVID S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +140,041 | 140,041 | ||
| 2026-01-22 | Grossman Fred Chief Medical Officer | Grant or award · Stock Option (right to buy) | +140,041 | 140,041 | ||
| 2026-01-22 | Berman Howard Executive Chairman | Grant or award · Stock Option (right to buy) | +15,257 | 15,257 | ||
| 2026-01-22 | Swaminathan Arun Chief Executive Officer | Grant or award · Stock Option (right to buy) | +293,983 | 293,983 | ||
| 2026-01-02 | Villalobos Anabella Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-01-02 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-01-02 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-01-02 | ROSS WILBUR L JR Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-01-02 | Lee Ann Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-08-18 | GOLDSTEIN DOV A MD Director | Option exercise | +17,557 | $1.09 | $19K | 27,557 |
| 2025-08-18 | GOLDSTEIN DOV A MD Director | Option exercise · Stock Option (right to buy) | −17,557 | 0 | ||
| 2025-02-25 | Lee Ann Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-02-25 | Villalobos Anabella Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-02-25 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-02-25 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-02-25 | ROSS WILBUR L JR Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-09 | SNYDER DAVID S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +140,562 | 140,562 | ||
| 2025-01-09 | Swaminathan Arun Chief Executive Officer | Grant or award · Stock Option (right to buy) | +240,964 | 240,964 | ||
| 2025-01-09 | Grossman Fred Chief Medical Officer | Grant or award · Stock Option (right to buy) | +140,562 | 140,562 |
Page 1 of 4 · 65 trades